FDA Orange Book · active-ingredient family
Meloxicam; rizatriptan benzoate
Meloxicam; rizatriptan benzoate is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:SYMBRAVO · NDA 215431
1
Brand (NDA)
0
Generics (ANDA)
94
Listed patents
1
Exclusivity periods
Brand (NDA) products · tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| SYMBRAVORLD | AXSOME | NDA 215431 | — | Jan 30, 2025 |
Marketing exclusivity (1)
- NPNew product exclusivity (3 years)
Jan 30, 2028
in 1 yr 8 mo
Listed patents (94)
| Patent | Expires | In | Type |
|---|---|---|---|
| 10702535 | Apr 11, 2036 | in 9 yr 11 mo | U-4136 |
| 10702602 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11013806 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10722583 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10987358 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10729696 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10688102 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11865117 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10729697 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11617755 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10729773 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10517950 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11426414 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 9821075 | Apr 11, 2036 | in 9 yr 11 mo | ProductU-1719 |
| 10029010 | Apr 11, 2036 | in 9 yr 11 mo | U-4133 |
| 10137131 | Apr 11, 2036 | in 9 yr 11 mo | ProductU-1719 |
| 10195278 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10695429 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10265324 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11369684 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10695430 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10363312 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10688185 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10653777 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10583144 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11331323 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10561664 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10537642 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10369224 | Apr 11, 2036 | in 9 yr 11 mo | U-4134 |
| 10532101 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11285213 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10426839 | Apr 11, 2036 | in 9 yr 11 mo | U-4135 |
| 10471014 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11219626 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10471069 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10512692 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11207328 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10512693 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11135295 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11045549 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11020483 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11826370 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10940153 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11602563 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11806354 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11510927 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10933137 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11504429 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11471464 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10933136 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11801250 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10799588 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10780165 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10821181 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11759522 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10758618 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10918722 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11738085 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11013805 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11712441 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10905693 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11628173 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10894053 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11617791 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10821182 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11617756 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11607456 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11571428 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11471465 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10780166 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10758617 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 12485176 | Apr 11, 2036 | in 9 yr 11 mo | U-4133 |
| 10265400 | Apr 11, 2036 | in 9 yr 11 mo | U-4509 |
| 10265399 | Apr 11, 2036 | in 9 yr 11 mo | U-4509 |
| 10307484 | Apr 11, 2036 | in 9 yr 11 mo | U-4509 |
| 10369225 | Apr 11, 2036 | in 9 yr 11 mo | U-4356 |
| 10456471 | Apr 11, 2036 | in 9 yr 11 mo | U-4509 |
| 11266657 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11433078 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11433079 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 11944683 | Apr 11, 2036 | in 9 yr 11 mo | U-1719 |
| 10058614 | Apr 11, 2036 | in 9 yr 11 mo | Product |
| 10463736 | Apr 11, 2036 | in 9 yr 11 mo | Product |
| 12472257 | May 18, 2038 | in 12 yr 1 mo | U-4134 |
| 12472256 | May 18, 2038 | in 12 yr 1 mo | U-4356 |
| 12616752 | May 18, 2038 | in 12 yr 1 mo | U-4510 |
| 12472258 | May 18, 2038 | in 12 yr 1 mo | Product |
| 12551489 | May 28, 2040 | in 14 yr 2 mo | U-1719 |
| 12551488 | May 28, 2040 | in 14 yr 2 mo | U-1719 |
| 12128052 | May 28, 2040 | in 14 yr 2 mo | U-1719 |
| 12370196 | Dec 29, 2041 | in 15 yr 9 mo | U-1719 |
| 12611413 | Dec 29, 2041 | in 15 yr 9 mo | U-1719 |
| 12005118 | Jan 25, 2043 | in 16 yr 10 mo | U-1719 |
| 12544383 | Mar 10, 2045 | in 19 yr | U-1719 |
Meloxicam; rizatriptan benzoate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

